Key Events This Week
23 Mar: Stock surges 3.92% amid Sensex decline
24 Mar: Mojo Grade upgraded to Hold; technical momentum shifts
25 Mar: Moderate gain of 0.96% continues upward trend
27 Mar: Slight dip of 0.21% closes week at Rs.1,235.05

Entero Healthcare Solutions Ltd Upgraded to Hold on Improved Technicals and Financials
2026-03-24 08:48:11Entero Healthcare Solutions Ltd has seen its investment rating upgraded from Sell to Hold as of 23 March 2026, reflecting a marked improvement in its technical outlook alongside sustained financial strength. The company’s Mojo Score now stands at 54.0, signalling a more balanced risk-reward profile for investors amid a volatile retailing sector.
Read full news article
Entero Healthcare Solutions Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-03-24 08:05:11Entero Healthcare Solutions Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend. This change comes amid a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively paint a nuanced picture for investors in this small-cap retailing stock.
Read full news articleWhy is Entero Healthcare Solutions Ltd falling/rising?
2026-03-24 01:37:40
Stock Performance Surpasses Market Benchmarks
Entero Healthcare Solutions has delivered impressive returns relative to the Sensex and its sector over recent periods. In the past week, the stock surged by 15.72%, sharply contrasting with the Sensex’s decline of 3.72%. Over the last month, the stock gained 8.97%, while the Sensex fell by 12.72%. Year-to-date, Entero Healthcare’s rise of 12.96% stands in stark relief against the Sensex’s 14.70% drop. Even though the stock’s one-year return is slightly negative at -0.97%, it still outperforms the Sensex’s -5.47% over the same period. This relative strength highlights investor confidence in the company’s prospects amid broader market volatility.
Strong Intraday and Short-Term Price Movements
On 23-Ma...
Read full news article
Entero Healthcare Solutions Ltd is Rated Sell
2026-03-20 10:10:45Entero Healthcare Solutions Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Entero Healthcare Solutions Ltd Hits Intraday High with 7.12% Surge
2026-03-18 12:16:06Entero Healthcare Solutions Ltd demonstrated a robust intraday performance on 18 Mar 2026, surging 7.12% to touch a day’s high of Rs 1098.45. The stock outperformed its sector and the broader market, continuing its recent upward momentum with notable trading activity.
Read full news article
Entero Healthcare Solutions Ltd is Rated Sell
2026-03-09 10:10:56Entero Healthcare Solutions Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleEntero Healthcare Solutions Ltd Falls 4.14%: Valuation Shifts and Mixed Signals Shape Weekly Performance
2026-02-28 09:04:00
Key Events This Week
23 Feb: Upgraded to Hold on improved valuation and financial metrics
23 Feb: Valuation rating shifted to Very Attractive amid mixed market performance
26 Feb: Downgraded to Sell reflecting mixed financial and valuation signals
27 Feb: Week closes at Rs.1,036.15 (-4.14%)

Entero Healthcare Solutions Ltd Downgraded to Sell Amid Mixed Financial and Valuation Signals
2026-02-26 08:22:36Entero Healthcare Solutions Ltd has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 25 February 2026, reflecting a reassessment across key parameters including valuation, financial trends, quality, and technical indicators. Despite some positive financial results, the stock’s underperformance relative to the broader market and evolving valuation metrics have prompted a more cautious stance.
Read full news articleClosure of Trading Window
23-Mar-2026 | Source : BSEIntimation of closure of trading window
Announcement under Regulation 30 (LODR)-Change in Management
11-Mar-2026 | Source : BSEChange in Senior Management Personnel
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
04-Mar-2026 | Source : BSEIntimation of Schedule of Analyst/Institutional Investor meet to be held on March 11 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






